These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

635 related articles for article (PubMed ID: 33555073)

  • 1. Pulmonary infection secondary to Blastobotrys raffinosifermentans in a cystic fibrosis patient: Review of the literature.
    Al-Obaidi M; Badali H; Cañete-Gibas C; Patterson HP; Wiederhold NP
    Mycoses; 2021 Jun; 64(6):616-623. PubMed ID: 33555073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Invasive mycosis due to species of Blastobotrys in immunocompromised patients with reduced susceptibility to antifungals.
    Kumar A; Babu R; Bijulal S; Abraham M; Sasidharan P; Kathuria S; Sharma C; Meis JF; Chowdhary A
    J Clin Microbiol; 2014 Nov; 52(11):4094-9. PubMed ID: 25165080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antifungal efficacy of isavuconazole and liposomal amphotericin B in a rabbit model of Exserohilum rostratum meningoencephalitis: A preclinical paradigm for management of CNS phaeohyphomycosis.
    Petraitis V; Petraitiene R; Katragkou A; Maung BBW; Moradi PW; Sussman-Straus GE; Naing E; Kovanda LL; Finkelman MA; Walsh TJ
    Med Mycol; 2021 Feb; 59(2):189-196. PubMed ID: 33313821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the Gradient Concentration Strip Method for Antifungal Susceptibility Testing of Isavuconazole and Comparators for
    Vidal P; Schwarz P; Dannaoui E
    Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31358578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of isavuconazole in a patient with voriconazole-induced QTc prolongation.
    Trang TP; Hanretty AM; Langelier C; Yang K
    Transpl Infect Dis; 2017 Aug; 19(4):. PubMed ID: 28434195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Invasive fungal infection caused by Blastobotrys mokoenaii in an immunocompromised patient with acute myeloid leukemia: A case report.
    Shiomi I; Makuuchi Y; Noura I; Kakuno S; Niki M; Kaimi Y; Ido K; Sakatoku K; Kuno M; Takakuwa T; Okamura H; Nishimoto M; Nakashima Y; Nakamae M; Kakeya H; Kohashi K; Hino M; Nakamae H
    J Infect Chemother; 2024 Jun; 30(6):557-561. PubMed ID: 38092335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breaking the Mold: A Review of Mucormycosis and Current Pharmacological Treatment Options.
    Riley TT; Muzny CA; Swiatlo E; Legendre DP
    Ann Pharmacother; 2016 Sep; 50(9):747-57. PubMed ID: 27307416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isavuconazole, micafungin, and 8 comparator antifungal agents' susceptibility profiles for common and uncommon opportunistic fungi collected in 2013: temporal analysis of antifungal drug resistance using CLSI species-specific clinical breakpoints and proposed epidemiological cutoff values.
    Pfaller MA; Rhomberg PR; Messer SA; Jones RN; Castanheira M
    Diagn Microbiol Infect Dis; 2015 Aug; 82(4):303-13. PubMed ID: 25986029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-world use-Isavuconazole at a large academic medical center.
    Hassouna H; Athans V; Brizendine KD
    Mycoses; 2019 Jun; 62(6):534-541. PubMed ID: 30851214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monotherapy or combination therapy of isavuconazole and micafungin for treating murine mucormycosis.
    Gebremariam T; Wiederhold NP; Alqarihi A; Uppuluri P; Azie N; Edwards JE; Ibrahim AS
    J Antimicrob Chemother; 2017 Feb; 72(2):462-466. PubMed ID: 27798213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful lung transplant in a child with cystic fibrosis and persistent Blastobotrys rhaffinosifermentans infection.
    Wong JY; Chambers AL; Fuller J; Lacson A; Mullen J; Lien D; Humar A
    Pediatr Transplant; 2014 Aug; 18(5):E169-73. PubMed ID: 24930454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isavuconazole MIC distribution of 29 yeast species responsible for invasive infections (2015-2017).
    Desnos-Ollivier M; Bretagne S; Boullié A; Gautier C; Dromer F; Lortholary O;
    Clin Microbiol Infect; 2019 May; 25(5):634.e1-634.e4. PubMed ID: 30771532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fungal infection of cystic fibrosis patients - single center experience.
    Garczewska B; Jarzynka S; Kuś J; Skorupa W; Augustynowicz-Kopeć E
    Pneumonol Alergol Pol; 2016; 84(3):151-9. PubMed ID: 27238177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular characterization and in vitro antifungal susceptibility of 80 clinical isolates of mucormycetes in Delhi, India.
    Chowdhary A; Kathuria S; Singh PK; Sharma B; Dolatabadi S; Hagen F; Meis JF
    Mycoses; 2014 Dec; 57 Suppl 3():97-107. PubMed ID: 25250768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of isavuconazole against Trichosporon, Rhodotorula, Geotrichum, Saccharomyces and Pichia species.
    Thompson GR; Wiederhold NP; Sutton DA; Fothergill A; Patterson TF
    J Antimicrob Chemother; 2009 Jul; 64(1):79-83. PubMed ID: 19406849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct in vitro comparison of the prodrug isavuconazonium sulfate with the isavuconazole active compound against Aspergillus spp. and 2 rare moulds.
    Pfaller MA; Rhomberg PR; Castanheira M
    Diagn Microbiol Infect Dis; 2018 Sep; 92(1):43-45. PubMed ID: 29735424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New triazoles and echinocandins: mode of action, in vitro activity and mechanisms of resistance.
    Fera MT; La Camera E; De Sarro A
    Expert Rev Anti Infect Ther; 2009 Oct; 7(8):981-98. PubMed ID: 19803707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful outcome of disseminated mucormycosis in a 3-year-old child suffering from acute leukaemia: the role of isavuconazole? A case report.
    Cornu M; Bruno B; Loridant S; Navarin P; François N; Lanternier F; Amzallag-Bellenger E; Dubos F; Mazingue F; Sendid B
    BMC Pharmacol Toxicol; 2018 Dec; 19(1):81. PubMed ID: 30522521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful Isavuconazole therapy in a patient with acute invasive fungal rhinosinusitis and acquired immune deficiency syndrome.
    Ahmed Y; Delaney S; Markarian A
    Am J Otolaryngol; 2016; 37(2):152-5. PubMed ID: 26954873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.